TETRAPHASE PHARMACEUTICALS INC Retained Earnings
TETRAPHASE PHARMACEUTICALS INC had Retained Earnings of -$616.25 million as of 2020-03-31, per its 10-Q filed 2020-05-07.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2020-05-07
- 2020-03-31: Retained Earnings (Accumulated Deficit) -$616.25M.
- 2019-12-31: Retained Earnings (Accumulated Deficit) -$604.13M.
- 2019-09-30: Retained Earnings (Accumulated Deficit) -$592.75M.
- 2019-06-30: Retained Earnings (Accumulated Deficit) -$576.45M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2020-03-31 | -$616.25M 10-Q · filed 2020-05-07 |
| 2019-12-31 | -$604.13M 10-Q · filed 2020-05-07 |
| 2019-09-30 | -$592.75M 10-Q · filed 2019-11-12 |
| 2019-06-30 | -$576.45M 10-Q · filed 2019-08-08 |
| 2019-03-31 | -$553.53M 10-Q · filed 2019-05-08 |
| 2018-12-31 | -$534.04M 10-K · filed 2020-03-12 |
| 2018-09-30 | -$512.56M 10-Q · filed 2018-11-09 |
| 2018-06-30 | -$493.00M 10-Q · filed 2018-08-02 |
| 2018-03-31 | -$483.46M 10-Q · filed 2018-05-03 |
| 2017-12-31 | -$461.88M 10-K · filed 2019-03-15 |
| 2017-09-30 | -$438.41M 10-Q · filed 2017-11-01 |
| 2017-06-30 | -$408.40M 10-Q · filed 2017-08-02 |
| 2017-03-31 | -$376.59M 10-Q · filed 2017-05-08 |
| 2016-12-31 | -$347.13M 10-K · filed 2018-03-06 |
| 2016-09-30 | -$324.67M 10-Q · filed 2016-11-03 |
| 2016-06-30 | -$303.56M 10-Q · filed 2016-08-04 |
| 2016-03-31 | -$286.39M 10-Q · filed 2016-05-04 |
| 2015-12-31 | -$269.65M 10-K · filed 2017-03-13 |
| 2015-09-30 | -$251.54M 10-Q · filed 2015-11-02 |
| 2015-06-30 | -$233.49M 10-Q · filed 2015-08-06 |
| 2015-03-31 | -$207.45M 10-Q · filed 2015-05-07 |
| 2014-12-31 | -$186.46M 10-K · filed 2016-02-25 |
| 2014-09-30 | -$165.91M 10-Q · filed 2014-11-10 |
| 2014-06-30 | -$151.71M 10-Q · filed 2014-08-12 |
| 2013-12-31 | -$119.72M 10-K · filed 2015-03-06 |